Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_assertion type Assertion NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_head.
- NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_assertion description "[TAF lines generated from melanoma patient biopsies were tested for their ability to inhibit the function of tumor antigen-specific T cells, before and following treatment with BRAF(V600E)-upregulated immune modulators.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_provenance.
- NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_assertion evidence source_evidence_literature NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_provenance.
- NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_assertion SIO_000772 22850568 NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_provenance.
- NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_assertion wasDerivedFrom befree-2016 NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_provenance.
- NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_assertion wasGeneratedBy ECO_0000203 NP1001889.RAjWdnDmP7nUqpMQVuUbwniM5HKREFhlkQH1K3N8fpa_o130_provenance.